ClinicaliQ Trial Snapshot
- Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism — Recruiting • Non-phase study • Mental Health / Psychiatry • NCT06234501.
- High-dose vitamin B6 showed no significant benefit for reducing anxiety or sensory sensitivity in autistic adults compared to placebo.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism. Conditions: Autism Interventions: Pyridoxal 5'-Phosphate (100 mg), Placebo Lead Sponsor: University of Reading Planned Enrollment: 40 participants